ATE176461T1 - Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte - Google Patents

Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte

Info

Publication number
ATE176461T1
ATE176461T1 AT94931136T AT94931136T ATE176461T1 AT E176461 T1 ATE176461 T1 AT E176461T1 AT 94931136 T AT94931136 T AT 94931136T AT 94931136 T AT94931136 T AT 94931136T AT E176461 T1 ATE176461 T1 AT E176461T1
Authority
AT
Austria
Prior art keywords
enantiemeric
analogues
leucine
amino acid
intermediate products
Prior art date
Application number
AT94931136T
Other languages
English (en)
Inventor
Nicholas Turner
James Winterman
Raymond Mccague
Original Assignee
Chirotech Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chirotech Technology Ltd filed Critical Chirotech Technology Ltd
Application granted granted Critical
Publication of ATE176461T1 publication Critical patent/ATE176461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT94931136T 1993-11-01 1994-11-01 Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte ATE176461T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322472A GB9322472D0 (en) 1993-11-01 1993-11-01 Chiral compounds and their preparation

Publications (1)

Publication Number Publication Date
ATE176461T1 true ATE176461T1 (de) 1999-02-15

Family

ID=10744442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931136T ATE176461T1 (de) 1993-11-01 1994-11-01 Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte

Country Status (10)

Country Link
US (1) US6180374B1 (de)
EP (1) EP0726891B1 (de)
JP (1) JPH09504304A (de)
AT (1) ATE176461T1 (de)
AU (1) AU676786B2 (de)
CA (1) CA2173205A1 (de)
DE (1) DE69416424T2 (de)
ES (1) ES2128592T3 (de)
GB (1) GB9322472D0 (de)
WO (1) WO1995012573A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529211C2 (de) * 1995-08-09 1999-01-14 Degussa Verfahren zur Herstellung von (R)-tertiär-Leucin
CA2250417A1 (en) * 1996-04-02 1997-10-09 Bayer Aktiengesellschaft Substituted phenyl keto enols as pesticides and herbicides
GB9607458D0 (en) * 1996-04-10 1996-06-12 Zeneca Ltd Enzymatic process for stereoselective preparation of therapeutic amides
US6130337A (en) * 1997-04-11 2000-10-10 Board Of Trustees Of Leland Stanford Junior University Enantiomerically enriched α,α-distributed amino acids and method
JP2000319241A (ja) * 1999-04-28 2000-11-21 Ihara Chem Ind Co Ltd フェニルアルカン酸アミド化合物の製造方法
WO2009063804A1 (ja) 2007-11-16 2009-05-22 Kaneka Corporation N-カルバモイル-tert-ロイシンの製造法
EP2238242B9 (de) 2008-01-03 2015-06-10 BASF Enzymes LLC Transferasen und oxidoreduktasen, dafür kodierende nukleinsäuren sowie verfahren zu ihrer herstellung und verwendung
KR20120026024A (ko) 2009-04-24 2012-03-16 가부시키가이샤 가네카 N-알콕시카르보닐-tert-류신의 제조법
US8835676B2 (en) 2011-03-21 2014-09-16 Divi's Laboratories Ltd. Process for the preparation of enantiomerically pure tert-leucine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541080A (en) 1991-11-01 1996-07-30 Wisconsin Alumni Research Fdn. Method for preparing L-alpha-amino acids
US5219731A (en) * 1991-11-01 1993-06-15 Wisconsin Alumni Research Foundation Method for preparing optically-active amino acid derivatives

Also Published As

Publication number Publication date
AU676786B2 (en) 1997-03-20
DE69416424D1 (de) 1999-03-18
ES2128592T3 (es) 1999-05-16
GB9322472D0 (en) 1993-12-22
CA2173205A1 (en) 1995-05-11
EP0726891A1 (de) 1996-08-21
EP0726891B1 (de) 1999-02-03
JPH09504304A (ja) 1997-04-28
DE69416424T2 (de) 1999-06-10
WO1995012573A1 (en) 1995-05-11
US6180374B1 (en) 2001-01-30
AU8001294A (en) 1995-05-23

Similar Documents

Publication Publication Date Title
ATE98702T1 (de) Gleichmaessiger, duenner diamantfilm sowie ein verfahren zu dessen herstellung.
EP0404146A3 (de) Anreicherung von Enantiomeren und stereoselektive Herstellung von chiralen Aminen
CA2083041A1 (en) Labeled compounds for use in a diagnostic breath test
DE68911362D1 (de) Verfahren zur Herstellung von Kohlenstoff- und Graphitgegenständen hoher Dichte.
BG101948A (en) Process for preparing pure enantiomers of tropic acid esters
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
ATE142243T1 (de) Polymer zu lichtunterstützter lichthärtung und verfahren zu seiner herstellung
DE69428912D1 (de) Verfahren zur herstellung von pentafluorethan
DE69312402D1 (de) Feststoffgenerator zur Herstellung von Sauerstoff unter hohem Druck
ATE232909T1 (de) Mikrobielle stämme zur produktion von sphingolipidbasen
DE69416424D1 (de) Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte
ATE25676T1 (de) Optisch einheitliche beta-lactame, deren herstellung und verwendung bei der herstellung von antimikrobiell wirksamen beta-lactamen sowie vorprodukte verwendbar zu deren herstellung.
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE69612086D1 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta-lactonresten
DE69230495D1 (de) Spurenelementreiches zusatzmittel, verfahren zu dessen herstellung, diese enthaltende zusammensetzung und deren verwendung
DK461787A (da) Fremgangsmaade til selektivt at foroege maengdeforholdet mellem enkelte hovedkomponenter af antibiotikum a/16686-kompleks
ATE125570T1 (de) Biokatalytisches verfahren zur herstellung von l- (-)-carnitin aus crotonobetain und stämme von proteeae zur verwendung in diesem verfahren.
DE69220326D1 (de) Verfahren zur Herstellung von Trans-L-Hydroxy-Prolin
DE59606567D1 (de) Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
DE3678081D1 (de) Verfahren zur herstellung von polyaminen, polyamine und deren verwendung zur herstellung von polyurethanen.
ATE214686T1 (de) Verfahren zur herstellung von fluorverbindungen aus den entsprechenden aminen
DE59206633D1 (de) Biotechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid und R-(-)-2,2-Dimethylcyclopropancarbonsäure
DE3781555D1 (de) Verfahren zur herstellung einer zwei diastereoisomerische n-acylaminosaeureester enthaltenden diastereoisomerischen mischung.
DE3688185D1 (de) Verfahren zur herstellung von urethanmodifizierten harzen und daraus hergestellte verbindungen.
DE69206192D1 (de) Zusammensetzung zur Herstellung von Kohlenstoffverbundmaterial, so erhaltenes Kohlenstoffverbundmaterial und Verfahren zu dessen Herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties